Experimental studies have shown that salvianolic acid B can significantly raise the activities of SOD, CAT, GSH-Px, and total antioxidant capacity (T-AOC) and reduce the levels of MDA, LDH, and NOS in cerebral ischemia model animals [66, 67]. The gene discussed is SOD1; the disease is brain ischemia.